Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Renal Insufficiency × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 4 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Venous Thrombosis 1 Venous Thromboembolism 1 Thyroid Diseases 1 Thrombosis 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Desmoid Tumors 1 Cysts 1 Colonic Neoplasms 1

Interventions

Dexamethasone 6 Lenalidomide 3 Bortezomib 3 pomalidomide 2 Kidney Transplantation 2 Bendamustine Hydrochloride 2 Azacitidine 2 vinflunine 1 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pevonedistat 1 mirabegron 1 glucarpidase 1 gamma-Glutamyl Hydrolase 1 copanlisib 1 carfilzomib 1 Topotecan 1 Thalidomide 1 Tablets 1 Stents 1 Sitagliptin Phosphate 1 Rituximab 1 Plasmapheresis 1 Paclitaxel 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03234335 2023-05-06

IRMYG

Centre Hospitalier Universitaire de Saint Etienne

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡